MindMed is a leading mental health biotech company, focusing on novel psychedelic derived medicines. With breakthrough clinical research in psychedelic medicine and treatments, utilizing novel AI digital measures, we are turning our vision to help millions of people around the world into reality.
Founded in 2019, we are continuously expanding our presence throughout North America, central Europe and Australia and are constantly searching for high impact individuals in various clinical, technological and business operations domains to strengthen our team.
MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.
The Senior Director – Global Marketing leads the successful development of a commercial strategy and the execution of marketing projects for investigational psychedelic-inspired medicines within MindMed’s pipeline.
The Senior Director – Global Marketing drives the maturation and strengthening of all pipeline assets during their various development phases and ensure their full commercial launch readiness should they progress toward late development and regulatory filing. She/he contributes to the creation or enhancement of company wide processes and initiatives related to pipeline and product commercialization. For all of these endeavors, she/he will apply a strong future thinking and scenario-based approach so that our pipeline assets are well-positioned to meet the needs of patients and customers in the near future.
This leader is on the cutting edge of innovation as MindMed prepares to bring to the market a set of new, game-changing treatments for patients with significant unmet psychiatric needs. These new medical treatments require an entirely new level of strategic engagement and business model, one that perfectly aligns critical priorities for patients, health care practitioners (HCP), payers, employers and MindMed.
The role has responsibility to autonomously interface with all key stakeholders across the company to provide strategic insight into customer needs (patients, caregivers, health care practitioners, payers, governments, policy makers, patient advocates, etc.) as well as effectively drive the integration of commercial and strategic considerations into early product development and pre-commercialization planning.
This is a cross functional role that will work closely across all internal functions, and external partners on Discovery, Pharmaceutical Development, Clinical Development, and/or commercial related projects.
The Senior Director – Global Marketing is a core member of Asset Program Team(s) and of Global Brand
Team(s).
The role reports to the Chief Commercial Officer.
Key Function and Responsibilities
- Lead the development and execution of the integrated strategy for any assets from MindMed’s pipeline (and licensing partnerships).
- Develop a comprehensive and credible view of commercial future needs to effectively launch a new medicine or indication, and ensure that any early commercial and strategic viewpoint is clearly communicated across the broader organization and aligned with all partners involved in the development of a product integrated strategy.
- Have a strong working level of knowledge of current science and novel mechanisms of action and modalities within the field of neurology and psychiatry.
- Be an active and engaged member of the broader Commercial Team to identify and address challenges and opportunities affecting early and late development as well as future launch success.
- Leverage a deep market understanding to develop product strategy, positioning and value proposition for target audiences, guide access/ reimbursement and policy planning, and inform clinical development plans to effectively address customer needs.
- Help develop a Commercial planning framework that enables the organization to develop a simple, clear and insightful commercialization process.
- Lead an effective collaboration across functional and divisional areas, and with key markets and regions, to ensure the commercial perspective is robust and consistently integrated during the product development process.
- Continue deep learning on the science and buying process/patient journey of the different key markets (US, selected EU markets, Japan).
- Develop in-depths relationships with global and regional scientific leaders across different therapeutic areas in neurology and psychiatry.
- Leverage knowledge of insight gathering and data analytics to maximize the patient and HCP-centered experience and value demonstration and affordability for payers, and ensure effective integration of this knowledge in the product development process.
Education, Experience, Knowledge, Abilities
Required:
- MBA, MSc or equivalent degree.
- Minimum of 10+ years of progressive experience in biotech or pharmaceutical industry, with increasing leadership responsibilities and accountabilities in global and US commercial (marketing, sales, strategic development, business development, market access) roles, including a deep understanding of related regulations and compliance considerations.
- Experience in new product development and/or drug discovery and development process.
- Experience in product launch from a strategic and operational perspective (US or Europe).
- Leadership: proven ability to lead in a matrixed organization with multiple stakeholders.
- Communication: proven ability to clearly articulate messages/information across the enterprise and to all levels, including highest levels of senior leadership, key stakeholders and key decision makers.
- Management/talent development: experience managing and developing direct reports, building talented teams and leveraging relationships to influence across a matrix structure, mentoring and retaining members at all levels of the organization.
- Strategic thinking: proven ability to analyze complex data and create clear patient and customer centric strategies.
- Excellent interpersonal skills and proven success working in a multi-functional team-based environment.
- Ability to work collaboratively across the organization to achieve corporate objectives.
- Ability to leverage data analytics to test hypotheses and develop strategic and tactical plans.
- Driven and result-oriented thinking and corresponding high level of performance.
- Excellent team management skills, ability to lead, train, mentor and retain team members at all levels.
Preferred:
- Advanced scientific degree (Doctoral degree, M.D., D.O., Ph.D., Pharm.D)
- Demonstrated ability in developing and executing a commercial product strategy (early development, pre-launch and launch phases, early life cycle management) and infrastructure in several key markets, including the United States.
- Strong track-record of building and developing an established network of relationships among the global thought leader community (psychiatry/neurology is preferred).
- Demonstrated ability in identifying and advancing business development opportunities and in effectively contributing to or leading partnership/alliance projects.
- Experience in leveraging digital approaches for successful product development and commercialization.
- Innovative thinking: demonstrated ability to leverage innovation to drive results.
- Experience working for one or more large pharma/biotechnology organizations.
- Experience working with R&D organization during discovery or development phase.
- Broad working knowledge of FDA and EMA requirements, industry compliance, clinical trial design and strategies, commercial and publication strategy, and medical information process
Work Environment and Travel Requirements
- The work is performed primarily in a remote office environment with occasional in-person meetings, and/or travel.
- Less than 30% travel at this time, and it may increase depending on the needs.